The cytochrome P450s metabolize a wide variety of xenobiotic and endogenous compounds. Biochemical, biophysical and computational approaches were applied to examine the structure-function relationships which govern the interactions of P450s with substrates, membrane lipids and microsomal proteins. The kinetics of CO binding to P450 was used as a probe of P450 conformation and dynamics, to define the effect of various drugs and carcinogens on P450s. Of particular interest is the finding that human P450 3A4, which metabolizes a variety of structurally dissimilar drugs, can assume alternate conformations. In contrast, the alcohol-inducible and carcinogen-metabolizing P450 2E1, which metabolizes a more narrow range of substrates, is more conformationally homogeneous. Ethanol, which stabilizes this P450, was found to reduce the CO binding rate and modulate its substrate interactions.We employed molecular modeling to generate a three dimensional structure of human P450 1A2. The active site structure was consistent with the relative inhibitory potencies of several flavonoids as well as three class 1B antiarrhythmics which inhibit this P450. We are currently employing this model to discover new P450 1A2 inhibitors. - Carcinogen metabolism, Computational methods, Cyotochrome P, 0, Drug Metabolism, Homology modeling, protein structure, Drug Metabolism, - Neither Human Subjects nor Human Tissues

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC005318-17
Application #
6289095
Study Section
Special Emphasis Panel (LMC)
Project Start
Project End
Budget Start
Budget End
Support Year
17
Fiscal Year
1999
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Michl, Josef; Scharf, Bruce; Schmidt, Anna et al. (2006) PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo. Int J Cancer 119:1577-85
Chie, Lyndon; Friedman, Fred K; Duncan, Thomas et al. (2004) Loop domain peptides from the SOS ras-guanine nucleotide exchange protein, identified from molecular dynamics calculations, strongly inhibit ras signaling. Protein J 23:229-34
Friedman, Fred K; Robinson, Richard C; Dai, Renke (2004) Molecular modeling of mammalian cytochrome P450s. Front Biosci 9:2796-806
Bustin, Michael; Robinson, Richard C; Friedman, Fred K (2004) Immunochemical analysis of chromatin. Methods Enzymol 376:209-20
Duncan, Thomas; Chen, James M; Friedman, Fred K et al. (2004) Comparison of molecular dynamics averaged structures for complexes of normal and oncogenic ras-p21 with SOS nucleotide exchange protein, containing computed conformations for three crystallographically undefined domains, suggests a potential role of these Protein J 23:217-28
Chie, Lyndon; Adler, Victor; Friedman, Fred K et al. (2004) An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21. Protein J 23:235-8
Dai, R; Pincus, M R; Friedman, F K (2000) Molecular modeling of mammalian cytochrome P450s. Cell Mol Life Sci 57:487-99
Smith, S V; Koley, A P; Dai, R et al. (2000) Conformational modulation of human cytochrome P450 2E1 by ethanol and other substrates: a CO flash photolysis study. Biochemistry 39:5731-7
Omata, Y; Dai, R; Smith, S V et al. (2000) Synthetic peptide mimics of a predicted topographical interaction surface: the cytochrome P450 2B1 recognition domain for NADPH-cytochrome P450 reductase. J Protein Chem 19:23-32
Wei, X; Dai, R; Zhai, S et al. (1999) Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide. J Pharmacol Exp Ther 289:853-8